Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

NCT05895136 is registered in ClinicalTrials.gov with European Foundation for Study of Chronic Liver Failure as lead sponsor.

NCT NCT05895136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Lead sponsor
European Foundation for Study of Chronic Liver Failure
Phase
Phase 2
Overall status
Recruiting
Start date
July 1, 2024
Completion date
October 31, 2026
Enrollment
90 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute on chronic liver failure (aclf), decompensated cirrhosis of liver, liver cirrhosis